Recent news on Streptokinase

FDA Approves Enoxaparin for STEMI  -  25 May 2007
Medscape (subscription)25 study that involved 25506 patients with STEMI who were scheduled to undergo fibrinolysis with streptokinase, tenecteplase, alteplase, or reteplase.

Intracoronary streptokinase improves microvascular perfusion after ...  -  May 2, 2007
TheHeart.Org,Istanbul, Turkey - Administration of low-dose intracoronary streptokinase immediately after primary PCI improved myocardial reperfusion but not long-term

Intracoronary Streptokinase after Primary Percutaneous Coronary ...  -  May 2, 2007
New England Journal of Medicine (subscription),To test this hypothesis, we evaluated the effect of low-dose intracoronary streptokinase administered immediately after primary PCI.

Clot-Preventing Drug Improves Heart Blood Flow After Angioplasty  -  May 3, 2007
Atlanta Journal Constitution (subscription),THURSDAY, May 3 (HealthDay News) -- Infusing the clot-preventing drug streptokinase improved blood flow in the tiniest heart blood vessels of people who had

Clot-busting drug shows promise following heart attack  -  May 2, 2007
Insider Medicine,One such drug under investigation is streptokinase, which is used to prevent and dissolve blood clots and to improve blood flow. To test whether this drug

The right to die  -  May 13, 2007
Ceylon Daily News,It was then the Consultant decided to give Streptokinase, a drug that help to dissolve the blood clot, which in turn helps to minimise the damage to the

The right and wrong way to think about heart attacks.  -  May 9, 2007
SlateBefore angioplasty became widespread, the only emergency treatment for heart attacks was to infuse clot-busting drugs like streptokinase into a patient's

Biologics Legislation Will Speed Progress  -  Apr 17, 2007
American Enterprise Institute,The competition between the older drug, streptokinase, and its newer rival, tPA, for the minds of doctors and the hearts of their patients should be a

New Guidelines for Treatment of Acute Ischemic Stroke  -  Apr 19, 2007
Medscape (subscription)Treatment with streptokinase is not recommended, and reteplase, urokinase, and other thrombolytic agents should not be used outside of the setting of a

Cuba Boosts Response to Heart Attacks  -  Jan 29, 2007
Prensa Latina,Bejucal, Cuba, Jan 29 (Prensa Latina) With the production of 79000 doses of recombinant streptokinase last year, Cuba upped manufacturing of this

Biocon to make UK, US foray  -  Jan 15, 2007
Economic Times,...used to increase the production of soldier white blood cells in cancer patients and streptokinase — a clot dissolving medication for heart patients.

Patentman fights for India  -  Jan 15, 2007
Rediff,A $100000 downpayment has already been made for this "clot specific streptokinase" which dissolves a clot without dangerously thinning blood.

Indian biotech has finally arrived on the global scene  -  Jan 3, 2007
Checkbiotech.org (press release),...skills coupled with a regulatory framework in place for approving generic versions of biologicals like Insulin, GCSF, Hep B vaccine, Streptokinase etc.

Indian drug cos eye West  -  Dec 29, 2006
Economic Times,...used to increase the production of soldier white blood cells in cancer patients and streptokinase — a clot dissolving medication for heart patients.

PCI ExTRACT-TIMI 25: Revascularization in Patients Receiving ...  -  Dec 29, 2006
Medscape (subscription)Mean age was 57 years in the overall patient cohort, 51% were current smokers, and 21% had received lytic streptokinase (Table).

Primary PCI for Myocardial Infarction with ST-Segment Elevation  -  Jan 3, 2007
New England Journal of Medicine (subscription),The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial

ThromboGenics Announces License Agreement with Bharat Biotech for ...  -  Dec 6, 2006
PharmaLive.com (press release),THR-100 has also shown superior efficacy to both streptokinase and urokinase, the most commonly used thrombolytic agents in the developing world for the

Merieux Alliance acquires majority stake in Shantha Biotechnics  09 Nov 2006
It has also developed branded recombinant streptokinase and a branded indigenous 4-in-1 combination vaccine that prevents diptheria, pertusis, tuberculosis and ... -domain-B, Fondaparinux in Patients With ST-Segment Elevation Myocardial ...  Oct 31, 2006
ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 ... -Journal of American Medical Association (subscription), Doctors Say Slow Action on Stents Leads to Heart Deaths  Oct 26, 2006
...used by the stenters increases the survival rates of people who have had heart attacks, compared with relying on clot-busting drugs like tPA and streptokinase. ... -New York Times, Management of Acute Coronary Syndrome Benefits From BNP Testing ...  Oct 27, 2006
As a result, treatments differed from Western standards, he said, such as streptokinase serving as the primary thrombolytic therapy. ... -DG News Administering drugs in neonates  Oct 25, 2006
...hydrocortisone, insulin, isoprenaline, labetalol, lidocaine, magnesium sulphate, morphine, noradrenaline, nitroprusside, streptokinase and tolazoline should be ... -Express Pharma, Clot-busters essential after heart attack  Sep 21, 2006
There are two types of clot busters. The ones that break up blood clots are Streptokinase, Urokinase and Tissue plasminogen activator (TPA). ... -NDTV.com

Cardiac Cell Therapy — Mixed Results from Mixed Cells  Sep 20, 2006
...[Abstract]. Anderson JL, Marshall HW, Bray BE, et al. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. ... -New England Journal of Medicine (subscription)

Five-year results from PRAGUE 2 confirm superiority of transfer ...  Sep 4, 2006
2—first reported four years ago—randomized 850 patients within 12 hours of STEMI onset to either treatment with thrombolysis (streptokinase) at their local ... -TheHeart.Org

ThromboGenics Announces License Agreement With Bharat Biotech for ...  -  Dec 7, 2006
PR Newswire (press release),THR-100 has also shown superior efficacy to both streptokinase and urokinase, the most commonly used thrombolytic agents in the developing world for the

New observations from OASIS-6/EXTRACT-TIMI 25  -  Nov 20, 2006
TheHeart.Org,Both these subgroup results from OASIS 6 and EXTRACT suggest that better antithrombin regimens benefit patients receiving streptokinase as well as those

Cuban biotechnology working for healthcare  -  Nov 14, 2006
Granma International,Herrera explained that the institution has initiated clinical trials of streptokinase applied rectally in order to prevent rectal infarctions,

Taking a global shot  -  Nov 26, 2006
Financial Express,...interferon-alpha and interferon-beta, human growth hormone, human follicle stimulating hormone, recombinant streptokinase, and others.

For biotech firms, US Democrats offer hope  -  Nov 24, 2006
Daily News & Analysis,Dr Reddy’s Labs, Shantha Biotechnics and Wockhardt have been marketing various biotech drugs like streptokinase, human insulin, G CSF, erythropoietin,

Heart of the matter  -  Nov 21, 2006
Newindpress (subscription),...o Thrombolytic treatment: IV streptokinase / IV urokinase / IV TPA infusion therapy. o Primary PTCA with stenting with or without drug coated stent.

Angioplasty advice  -  Nov 15, 2006
Newsday,For them, artery-opening drugs, such as tPA or streptokinase work best, Hochman said. Dr. David Hillis, vice chairman of medicine at the University of Texas

IMTECH develops GenNext clot-buster for heart patients  Aug 1, 2006
According to IMTECH scientists, the clot-specific clot-buster is a new molecule of the natural protein Streptokinase, and research into the new Streptokinase ... -Chandigarh Newsline

Indian scientists develop new SOS clotbuster  Jul 27, 2006
The SOS clotbuster is a new molecule of the natural protein Streptokinase designed by researchers at the state-run Institute of Microbial Technology (IMTECH ... -Hindustan Times

TECHNOLOGY LICENSING AGREEMENT SIGNED BETWEEN IMTECH AND US ...  Jul 27, 2006
The therapeutic protein licensed to Nostrum is known as Clot Specific Streptokinase (CSSK), which was developed at IMTECH, CSIR. ... -Press Information Bureau

Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From ...  Jul 27, 2006
The therapeutic protein being licensed by Nostrum is known as Clot Specific Streptokinase (CSSK), which was developed at IMTECH by Dr. Girish Sahni, Director ... -Yahoo! News

Alfimeprase to succeed Genentech's alteplase?  Aug 2, 2006
...of the US anti-clotting market was slow because mortality rates were only marginally better than the standard of treatment at the time—bacterial streptokinase ... -Nature.com (subscription)

Indian scientists ready with clot buster  Jul 28, 2006
The clot buster is a new molecule of the natural protein Streptokinase designed by researchers at the state-run Institute of Microbial Technology in Chandigarh ... -NDTV.com

New feather in CSIR's cap  Jul 30, 2006
...this week as the first payment for acquiring worldwide licensing rights for the molecule, which promises to be better than Streptokinase, the traditional ... -Hindu

Nostrum gets worldwide rights to novel clot-buster  Jul 28, 2006
The therapeutic protein being licensed by Nostrum is known as clot-specific streptokinase (CSSK), which was developed at The Institute of Microbial Technology ... -Pharmaceutical Business Review

New Trials of Antithrombotic Therapy for ACS -- ACC 2006  Jul 21, 2006
In brief, ExTRACT-TIMI 25 was a trial of patients who presented with STEMI and were receiving thrombolytic therapy with TNK, tPA, rPA, or streptokinase at the ... -Medscape (subscription)

Biotech: Cuban Health Mainstay  Jun 28, 2006
...development, explaining how it currently produces 18 medicines, among them four vaccines, others like interferon and recombinant streptokinase and the Citroprob ... -Escambray

Cuban Genetics and Biotechnology Turns 20  Jul 1, 2006
CIGB boasts 18 products: monoclonal antibodies, a vaccines for hepatitis B, recombinant streptokinase (cardiac arrest), cancer vaccines, epidemic growth factor ... -Prensa Latina

Cuban Biotechnology: World Class Science for the World's Well ...  Jul 5, 2006
Another drug that has come out of Cuban laboratories is recombinant streptokinase, which is provided in all of the country's intensive care units and used in ... -Periódico 26

HERO-2 analysis cements prognostic powers of Q wave at AMI ...  Jun 22, 2006
The main HERO-2 trial compared bivalirudin with heparin, administered at the same time as streptokinase and aspirin in all patients. ... -TheHeart.Org

Measuring Hospital Quality What Physicians Do? How Patients Fare? ...  Jul 4, 2006
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. ... -Journal of American Medical Association (subscription)



Fondaparinux in ST-Segment Elevation Myocardial Infarction  Apr 4, 2006
Furthermore, among patients treated with fibrinolytic therapy, the majority (73%) were treated with streptokinase, but a significant minority received tissue ... - Journal of American Medical Association (subscription)

B vitamins fail to help heart  Mar 19, 2006
If a patient cannot get to a hospital for angioplasty soon enough, however, the alternative is to use clot-busting drugs, such as tPA and streptokinase. ... - Los Angeles Times

ACC: Arixtra Reduces Mortality in Patients with STEMI  Mar 14, 2006
...randomized assignment. Some patients also received fibrinolytic therapy, either with streptokinase or tissue plasminogen activator. The ... - MedPage Today



Cuba ties put 'cartoonish' violence near US shores  Feb 10, 2006
...solely) for the purpose of protecting all the children in the Middle East from hepatitis, or treating their people with cheap streptokinase when they suffer ... - Houston Chronicle,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional